Lorrain Daniel S. (CIK 1861550) reported 27 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-10). Recent activity: Buy CTNM (1,015 shares), Sell CTNM (1,015 shares), Buy CTNM (25 shares), Sell CTNM (25 shares), Buy CTNM (28,826 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-10 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Buy | 1,015 | $1,025 |
| 2026-07-10 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 1,015 | $16,240 |
| 2026-07-10 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Buy | 25 | $25 |
| 2026-07-10 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 25 | $400 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Buy | 28,826 | $29,114 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 28,826 | $462,288 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Buy | 4,183 | $4,225 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 5,852 | $91,682 |
| 2026-07-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 2,501 | $40,608 |
| 2026-06-01 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 4,170 | $54,862 |
| 2026-05-01 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 3,870 | $50,542 |
| 2026-05-01 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 300 | $4,152 |
| 2026-04-06 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 4,170 | $56,014 |
| 2026-03-02 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 4,170 | $62,592 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Buy | 4,300 | $4,343 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 4,300 | $68,929 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Buy | 3,824 | $3,862 |
| 2026-02-26 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 3,824 | $61,222 |
| 2026-02-20 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Buy | 100 | $101 |
| 2026-02-20 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 100 | $1,600 |
| 2026-02-13 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Buy | 400 | $404 |
| 2026-02-13 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 400 | $6,400 |
| 2026-02-05 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 3,000 | $44,460 |
| 2026-02-05 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 1,170 | $17,842 |
| 2026-01-06 | Contineum Therapeutics, Inc. (CTNM) | Chief Scientific Officer | Sell | 3,670 | $37,984 |
Source: SEC Form 4 filings · as of 2026-07-10